1 / 34

Pediatric Hematology

Pediatric Hematology. Dr. Mariana Silva, MD.F.R.C.P.C. March 2008. FETAL AND NEONATAL ERYTHROPOIESIS. TABLE 1. Globin-chain development and composition. a This tetramer may be an epsilon tetrad.

Rita
Télécharger la présentation

Pediatric Hematology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pediatric Hematology Dr. Mariana Silva, MD.F.R.C.P.C. March 2008

  2. FETAL AND NEONATAL ERYTHROPOIESIS TABLE 1. Globin-chain development and composition aThis tetramer may be an epsilon tetrad. bFetal hemoglobin produced by adults has a different amino acid heterogeneity of the gamma chain atthe 136 position than fetal hemoglobin

  3. Site of Erythropoiesis

  4. Hemoglobin Synthesis inFetus and Newborn Gower 1 and 2 - present in yolk sac - 75% of early Hgb - undetectable after week 12 Week 12 to 32  90% Hgb F

  5. Hemoglobin Synthesis inFetus and Newborn (cont’d) “The Switch” is Hgb F to A Hgb F  after week 32; by week 40 is 50-75%; by 6 month is 5-8%; by 1 year < 1% Delayed Switch (? mechanism ? Stress Erythropoiesis) . Maternal hypoxia . Small for Gestational Age . Infants of diabetic mothers

  6. Physiological Anemia of Infancy • Gradual  in Hgb after birth for 2 months, stable 2-4 month, then  • Physiologic as no symptoms of hypoxia and not nutritional Fetus - 10 weeks Hgb 9 gr/dl - 22-24 week, Hgb 14 gr/dl - 32-40 week, Hgb 16 gr/dl

  7. Physiological Anemia of Infancy (cont’d) age:  blood supply to placenta  Epo to maintain oxygen supply to infant Hemoglobin (Hgb) Oxygen delivery to fetus determines Hgb level at birth. Examples: • Small for gestational • Infant of diabetic mother:  metabolic demands on fetus from  glucose  oxygen needs Hemoglobin • Infants of smokers:  fetal CO  oxygen available  Hemoglobin to compensate • Infants gestated at  altitudes:  inspired oxygen by mothers  Hemoglobin in newborn

  8. Physiological Anemia of Infancy (cont’d) • Birth:  Hemoglobin (Hgb) due to placental transfusion •  RBC production after birth due to  availability of extrauterine oxygen • 2 month of age  Hgb due to  RBC production, shorter life fetal RBC • Nadir at 7-9 wk of age: Hgb 11 gr./dl

  9. Physiological Anemia of Infancy (cont’d)  placental transfusion in: • placenta previa or abruptio • multiple gestation • cord clamping < 30 seconds • C-section • Cord around neck 24-32 week retics are 15% of RBC’s, at birth 7% Day 7, retics  to 1%

  10. Postnatal changes in hemoglobin and ared-blood-cell indices in term infants

  11. Anemia of Prematurity • Premature Infant: more rapid decline and lower nadir of Hgb than term 40% infants <33 weeks show symptoms of anemia • Epo  rapidly, Epo levels 50% < than adults at same Hgb level • Epo  slowly as Hgb falls in premature babies Epo produced in liver

  12. Anemia of Prematurity (cont’d) Decision to transfuse  controversy for last 30 years • Anemia  risk of apnea and failure to thrive. • Transfusion at predetermined Hgb level not cost effective and doesn’t  apnea

  13. Sites and Timing of Neonatal Blood Loss A Fetus 1. Internal hemorrhage 2. Fetomaternal Hemorrhage 3. Fetoplacental hemorrhage: abruption,previa, marginal sinus ,or hematoma 4. Twin-twin transfusion: chronic

  14. Sites and Timing of Neonatal Blood Loss (cont.) BNewborn 1. Twin-Twin transfusion: acute 2. Umbilical-cord rupture or hematoma-normal or abnormal cord 3. Internal hemorrhage: Intracranial, hepatic or splenic rupture or hematoma, adrenal or retroperitoneal hematoma. Pulmonary bleed 4. Placental trapping: caesarean section, early cord clamping, precipitous delivery

  15. Fe Deficiency Anemia • Most common etiology of anemia Lack of dietary iron • Contributing factors in children Rapid growth Insufficient Fe • Absorption • Blood loss Breast milk or formula vs. cow’s milk • Diet Cereals Meat

  16. Fe Deficiency Anemia (cont’d) • Lab : Hemoglobin MCV  Serum Fe/TIBC Serum Ferritin • Platelets frequently  • “Trial of Fe” • Treatment: Oral ferrous sulfate  5-6 mg/kg of elemental Fe x day x 3 months • Side effects of Fe

  17. THROMBOPOIESIS IN FETUS AND NEWBORN

  18. Thrombopoiesis I Yolk sac phase: • small megakaryocytes by 5 week, • platelets large and hypogranular II Hepatic phase: • early stage by 6 week • Megakaryoblasts and promegakaryocytes seen • late stage: 9-11 weeks Megakaryocytes comparable to adult, but smaller

  19. Thrombopoiesis (cont’d) III Bone Marrow phase: after 11 weeks • from 11 to 22 stable number megakaryocytes, then  22 to 40 week. Size still small, adult size by one year of age. • Newborns easily develop thrombocytopenia due to sepsis. Little is known of newborn megakaryocytopoietic-thrombopoietic capacity

  20. WELL Large platelets Normal hemoglobin and WBC SmallPlatelets Congenital anomalies Mean corpuscular volume Consumption Synthesis Immune Congenital ITP 2° to SLE, HIV Drug Induced TAR Wiskott-Aldrich Syndrome X-linked Amegakaryocytic Fanconi anemia Maternal ITP NATP Non-immune 2B or platelet-type vWd Hereditary macrothrombocytopenia Acquired: Medications,Toxins,Radiation

  21. ILL Fibrinogen Fibrin degradation products Large platelets Small platelets HSM Mass Synthesis Consumption Microangiopathy Hemolytic-uremic syndrome TTP Malignancy Storage disease Sequestration Disseminated intravascular coagulation Necrotizing enterocolitis Respiratory distress ThrombosisUAC Sepsis Viral infection Hemangioma Hypersplenism

  22. Thrombocytopenia • Infant Factors Platelet < 100,000/mm3 in 80% sick infants 60% known etiology • 22% infants in NICU have  platelets Approximately 25% have significant bleeding •  platelets associated with: sepsis, respiratory distress,  bilirubin, ventilation, asphyxia, meconium, hypothermia, pulmonary hypertension, polycythemia • Sepsis  52-77% have  platelets, may be 1st manifestation. Mean duration 5 days.

  23. CLINICAL CASES ITyler is an 11- month- old boy brought to your office by his mother who thinks he is pale and a bit irritable. He has not had any recent illnesses and is on no medications. • History of presenting complaint • Past medical history • Diet • Family History • Physical Exam

  24. LAB Hb 82 g/L MVC 65 WBC 6.9 x 109/L Platelets 540,000 x 109/L • Possible diagnosis • Treatment

  25. CLINICAL CASES (cont’d) II Amanda is a 2-month-old girl you are seeing today for her lst immunization. Her mother reports that Amanda sleeps a lot and looks pale. She is growing well and breastfeeds vigorously. She is on no medications. • History of presenting complaint • Past medical history • diet • Family history • Physical exam

  26. LAB 0 Hb 102 g/L MCV 84 WBC 8.3 x 109/L Platelets 240,000 x 109/L • Possible diagnosis • How would you manage this patient?

  27. Pancytopenia Reduction below normal values of 3 blood lines: *Leukocytes * Platelets * Erythrocytes Hypocellular Marrow Seen in: Constitiutional (Inherited) marrow failure syndromes Acquired Aplastic Anemia Hypoplastic Variant of Myelodysplastic Syndromes

  28. Pancytopenia (con’t) Cellular marrow seen in: • Primary bone marrow disease as Acute Leukemia, MDS, Myelofibrosis • Secondary to systemic disease: autoimmune disease (SLE), Vitamin B12 or folate deficiency, storage disease, metastatic solid tumors, etc.

  29. Constitutional (Inherited) Pancytopenia Syndromes Fanconi Anemia Shwachman-Diamond Syndrome Dyskeratosis Congenita Amegakaryocytic Thrombocytopenia Other Genetic Syndromes Down Syndrome Dubowitz Syndrome Seckel Syndrome Reticular Dysgenesis Schimke Immuno-Osseous Dysplasia Familial Aplastic Anemia (non-Fanconi) Pearson Syndrome Reticular Dysgenesis Noonan Syndrome

  30. Fanconi (Aplastic) Anemia • Autosomal recessive syndrome • Hematological findings • Typical physical anomalies • Abnormal chromosomal fragility

  31. Anomaly Skin Pigment Changes Short Stature Upper Limb Abnormalities (thumbs,hands,radi,ulnas) Hypogonadal and Genital Changes (mostly males) Other Skeletal Findings (head/face,neck,spine) Eye/lid/epicanthal fold anomalies Renal Malformations Ear Anomalies (external & internal), deafness Hip, leg, foot, toe abnormalities Gastrointestional/cardiopulmonary malformations Approximate Frequency (% of Patients) 65 60 50 40 30 25 25 10 10 10 Characteristic Physical Anomalies in Fanconi Anemia

  32. Marrow Failure Before Age 10 Years • Thrombocytopenia often first • Granulocytopenia • Macrocytic Anemia • Severe Aplastic Anemia in Most Cases • Increased Propensity for Cancer: Carcinomas of Head, Neck, Carcinoma of Vulva and Anus

  33. Treatment • Transfusions • Hematolpoietic Stem Cell Transplant is only Curative Treatment • Androgens – Prednisone Prognosis: Median Survival is >30 years of Age

More Related